Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Regadenoson in the rehabilitation of marginal donor lungs on ex vivo lung perfusion: A blinded multicenter randomized controlled clinical trial

JTCVS Open(2025)10.1016/j.xjon.2025.09.017Source: DataRank Database

Regadenoson in the rehabilitation of marginal donor lungs on ex vivo lung perfusion: A blinded multicenter randomized controlled clinical trial is a research paper published in JTCVS Open (2025). On theSindex it has a DataRank of 0. It has been cited 1 time.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access1 citations

Download PDF

Cite:

Linked data & code

nct doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 1.09)OA: goldTopics (11)IDs (PubMed, PMC, OpenAlex)Annotations (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (15)

Mark R. Conaway ORCID,Joseph Rabin ORCID,Kaitlyn Vecere,Kaitlyn Masih,Yunge Zhao ORCID

Live enrichment

PubMed:41473042 PMC:PMC12745136 OpenAlex:https://openalex.org/W4414440172

NHLBI

Grant: I01 BX002299-05

NHLBI

Grant: R01AI145108-01

NHLBI

Grant: R01HL166402

NHLBI

Grant: P01 AI116501

NHLBI

Grant: R01HL128492

FWCI

1.09

Citation Percentile

0.8%

Citation Trend

2025

goldLicense: cc-by

journalhttps://doi.org/10.1016/j.xjon.2025.09.017

publisherhttps://doi.org/10.1016/j.xjon.2025.09.017

publisherhttps://api.elsevier.com/content/article/PII:S2666273625003110?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2666273625003110?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/41473042

Fields of Study

Transplantation: Methods and OutcomesMechanical Circulatory Support DevicesCardiac Ischemia and Reperfusion

Keywords

RegadenosonPlaceboLungEx vivoClinical trialPrimary Graft DysfunctionIschemic Reperfusion InjuryEvlp

Regadenoson in the rehabilitation of marginal donor lungs on ex vivo lung perfusion: A blinded multicenter randomized controlled clinical trial

FAIR Checklist

Authors (15)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)